人类甲型血友病的分子遗传学（凝血因子 VIII 缺乏症） - Suppr

Suppr

超能文献

Molecular genetics of hemophilia A in man (factor VIII deficiency).

作者信息

Antonarakis S E, Youssoufian H, Kazazian H H

出版信息

Mol Biol Med. 1987 Apr;4(2):81-94.

PMID:2888005

Abstract

摘要

相似文献

Molecular genetics of hemophilia A in man (factor VIII deficiency).人类甲型血友病的分子遗传学（凝血因子 VIII 缺乏症）

Mol Biol Med. 1987 Apr;4(2):81-94.

[Structure and function of factor VIII and factor IX gene and molecular DNA diagnosis in hemophilia A and B].[血友病A和B中凝血因子VIII和凝血因子IX基因的结构与功能及分子DNA诊断]

Z Arztl Fortbild (Jena). 1988;82(22):1116-22.

Gene analysis in haemophilia A--restriction fragment length polymorphism and molecular defects in the factor VIII gene.

Nihon Ketsueki Gakkai Zasshi. 1988 Dec;51(8):1680-8.

Molecular etiology of factor VIII deficiency in hemophilia A.甲型血友病中凝血因子 VIII 缺乏的分子病因学。

Hum Mutat. 1995;5(1):1-22. doi: 10.1002/humu.1380050102.

Molecular basis of hemophilia.血友病的分子基础。

Hematol Pathol. 1990;4(1):1-26.

Molecular genetics of coagulation factor VIII gene and hemophilia A.

Thromb Haemost. 1995 Jul;74(1):322-8.

The cloning of factor VIII and the genetics of hemophilia A.凝血因子VIII的克隆与甲型血友病的遗传学

Hosp Pract (Off Ed). 1986 May 15;21(5):111-6.

Factor VIII gene mutations and RFLP analysis in hemophilia A.甲型血友病中凝血因子VIII基因突变与限制性片段长度多态性分析

Stem Cells. 1993 May;11 Suppl 1:72-6. doi: 10.1002/stem.5530110615.

Expression of cloned human factor VIII and the molecular basis of gene defects that cause hemophilia.

Prog Clin Biol Res. 1986;211:297-302.

The molecular genetics of hemophilia: blood clotting factors VIII and IX.血友病的分子遗传学：凝血因子VIII和IX

Cell. 1985 Sep;42(2):405-6. doi: 10.1016/0092-8674(85)90094-7.

引用本文的文献

Joint Effects of GWAS SNPs in Coagulation System Confer Risk to Hypertensive Intracerebral Hemorrhage.凝血系统 GWAS SNP 的联合作用导致高血压性脑出血的发病风险增加。

Neuromolecular Med. 2017 Sep;19(2-3):395-405. doi: 10.1007/s12017-017-8453-y. Epub 2017 Jul 17.

Strategies to target long-lived plasma cells for treating hemophilia A inhibitors.靶向长寿浆细胞治疗血友病A抑制物的策略。

Cell Immunol. 2016 Mar;301:65-73. doi: 10.1016/j.cellimm.2016.01.005. Epub 2016 Jan 18.

In vivo expansion of regulatory T cells with IL-2/IL-2 mAb complexes prevents anti-factor VIII immune responses in hemophilia A mice treated with factor VIII plasmid-mediated gene therapy.IL-2/IL-2 mAb 复合物体内扩增调节性 T 细胞可预防接受因子 VIII 质粒介导基因治疗的血友病 A 小鼠抗因子 VIII 免疫反应。

Mol Ther. 2011 Aug;19(8):1511-20. doi: 10.1038/mt.2011.61. Epub 2011 Apr 5.

Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium.多个遗传位点与血浆因子 VII、因子 VIII 和血管性血友病因子水平的新关联：CHARGE（基因组流行病学中的心脏和衰老研究队列）联盟。

Circulation. 2010 Mar 30;121(12):1382-92. doi: 10.1161/CIRCULATIONAHA.109.869156. Epub 2010 Mar 15.

Genetic induction of immune tolerance to human clotting factor VIII in a mouse model for hemophilia A.在甲型血友病小鼠模型中对人凝血因子 VIII 的免疫耐受的基因诱导。

Proc Natl Acad Sci U S A. 1998 May 12;95(10):5734-9. doi: 10.1073/pnas.95.10.5734.

Gene therapy for hemophilia A: production of therapeutic levels of human factor VIII in vivo in mice.血友病A的基因治疗：在小鼠体内产生治疗水平的人凝血因子VIII

Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):1023-7. doi: 10.1073/pnas.92.4.1023.

An initiator codon mutation in ornithine-delta-aminotransferase causing gyrate atrophy of the choroid and retina.鸟氨酸-δ-氨基转移酶中的起始密码子突变导致脉络膜和视网膜的回旋状萎缩。

J Clin Invest. 1988 Feb;81(2):630-3. doi: 10.1172/JCI113365.

The CpG dinucleotide and human genetic disease.CpG二核苷酸与人类遗传疾病。

Hum Genet. 1988 Feb;78(2):151-5. doi: 10.1007/BF00278187.

Restriction endonuclease mapping of six novel deletions of the factor VIII gene in hemophilia A.甲型血友病中因子VIII基因六个新缺失的限制性内切酶图谱分析

Hum Genet. 1988 Oct;80(2):143-8. doi: 10.1007/BF00702857.

Moderately severe hemophilia A resulting from Glu----Gly substitution in exon 7 of the factor VIII gene.由于凝血因子VIII基因第7外显子中谷氨酸被甘氨酸取代导致的中度严重甲型血友病。

Am J Hum Genet. 1988 Jun;42(6):867-71.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验